Safety and Efficacy of [177Lu]Lu-rhPSMA-10.1 Re-Challenge Therapy in Progressive mCRPC after [177Lu] Lu-PSMA I&T Therapy: Preliminary Results

被引：0
|
作者：
Gaeble, A. [1 ]
Enke, J. [1 ]
Amerein, A. [1 ]
Viering, O. [1 ]
Rinscheid, A. [2 ]
Kircher, M. [1 ]
Wienand, G. [1 ]
Pfob, C. [1 ]
Lapa, C. [1 ]
Dierks, A. [1 ]
Bundschuh, R. [1 ]
机构：
[1] Univ Augsburg, Nucl Med, Fac Med, Augsburg, Germany
[2] Univ Hosp Augsburg, Med Phys & Radiat Protect, Augsburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0565
引用
收藏
页码：S654 / S655
页数：2
相关论文
共 50 条
  • [31] Clinical dosimetry in [177Lu]Lu-PSMA therapy: fewer imaging time points, still useful
    De Vries-Huizing, D.
    Rijkhorst, E.
    Owers, E.
    De Wit-Van der Veen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S126 - S126
  • [32] Mathematic Modeling of Tumor Growth During [177Lu]Lu-PSMA Therapy: Insights into Treatment Optimization
    Zaid, Nouran R. R.
    Bastiaannet, Remco
    Hobbs, Rob
    Sgouros, George
    JOURNAL OF NUCLEAR MEDICINE, 2025, 66 (01) : 84 - 90
  • [33] Radionuclide therapy with 177Lu PSMA for prostate cancer
    da Rocha, Euclides Timoteo
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1527 - 1527
  • [34] Extravasation After [177Lu]Lu-HA-DOTATATE Therapy
    de Vries-Huizing, Daphne M. V.
    Cheung, Zing J.
    Hendrikx, Jeroen J. M. A.
    Donswijk, Maarten L.
    Versleijen, Michelle W. J.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (05) : 454 - 456
  • [35] Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure (vol 58, pg 381, 2024)
    Abdlkadir, Ahmed Saad
    Abufara, Alaa
    Al-Ibraheem, Akram
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 94 - 94
  • [36] Enhanced Therapeutic Effect of the Albumin-Binding [177Lu]Lu-Ibu-DAB-PSMA as Compared to [177Lu]Lu-PSMA-617-A Preclinical Therapy Study
    Tschan, V.
    Borgna, F.
    Schibli, R.
    Mueller, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S65 - S66
  • [37] Kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry
    Uijen, Maike J. M.
    Prive, Bastiaan M.
    van Herpen, Carla M. L.
    Westdorp, Harm
    van Gemert, Willemijn A.
    de Bakker, Maarten
    Gotthardt, Martin
    Konijnenberg, Mark W.
    Peters, Steffie M. B.
    Nagarajah, James
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (04) : 270 - 275
  • [38] Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer
    Santo, Giulia
    Santo, Gianpaolo Di
    Sviridenko, Anna
    Bayerschmidt, Steffen
    Wirth, Lukas
    Scherbauer, Fabian
    Lehmann, Peter
    von Guggenberg, Elisabeth
    Decristoforo, Clemens
    Heidegger-Pircher, Isabel
    Bektic, Jasmin
    Virgolini, Irene
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 52 (01) : 354 - 365
  • [39] Image-Based Bone Marrow Dosimetry in Patients Undergoing [177Lu]Lu-PSMA Radioligand Therapy
    Rumiantcev, M.
    Resch, S.
    Shen, X.
    Liubchenko, G.
    Brendel, M.
    Ziegler, S.
    Boening, G.
    Sheikh, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S164 - S164
  • [40] [177Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney Disease
    Mercolli, Lorenzo
    Mingels, Clemens
    Manzini, Giulia
    Cumming, Paul
    Zeimpekis, Konstantinos
    Xue, Song
    Alberts, Ian
    Uehlinger, Dominik
    Rominger, Axel
    Shi, Kuangyu
    Afshar-Oromieh, Ali
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (10) : 1570 - 1573
12345